• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Gladman.

作者信息

Landewé Robert Bm, Braun Juergen

机构信息

Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.

Rheumatology, Zuyderland MC, Heerlen, The Netherlands.

出版信息

Ann Rheum Dis. 2023 Aug;82(8):e188. doi: 10.1136/annrheumdis-2022-222359. Epub 2022 Apr 29.

DOI:10.1136/annrheumdis-2022-222359
PMID:35487678
Abstract
摘要

相似文献

1
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Gladman.对Gladman所著《关于“随机对照试验中抗IL-23疗法对轴向性脊柱关节炎无效，但在银屑病关节炎相关‘医生报告的脊柱炎’的事后分析中有效？”的通信》的回应
Ann Rheum Dis. 2023 Aug;82(8):e188. doi: 10.1136/annrheumdis-2022-222359. Epub 2022 Apr 29.
2
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.关于“随机对照试验中抗白细胞介素-23疗法对轴向性脊柱关节炎无效，但在银屑病关节炎相关‘医生报告的脊柱炎’的事后分析中有效？”的通信
Ann Rheum Dis. 2023 Aug;82(8):e187. doi: 10.1136/annrheumdis-2022-222161. Epub 2022 Apr 29.
3
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.关于“抗IL-23疗法在随机对照试验中对轴性脊柱关节炎无效，但在银屑病关节炎相关‘医生报告的脊柱炎’的事后分析中有效？”的通信
Ann Rheum Dis. 2023 Aug;82(8):e185. doi: 10.1136/annrheumdis-2021-221799. Epub 2021 Nov 29.
4
Response to: Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physicianreported spondylitis'?' by Siebert and Marzo-Ortega.对西伯特和马佐-奥尔特加所著《关于“随机对照试验中抗白细胞介素-23疗法对轴性脊柱关节炎无效，但在银屑病关节炎相关‘医生报告的脊柱炎’的事后分析中有效？”的通信》的回复
Ann Rheum Dis. 2023 Aug;82(8):e186. doi: 10.1136/annrheumdis-2021-221816. Epub 2021 Nov 29.
5
No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?在随机对照试验中，抗白细胞介素-23疗法对中轴型脊柱关节炎无效，但在银屑病关节炎相关的“医生报告的脊柱炎”的事后分析中是否有效呢？
Ann Rheum Dis. 2022 Apr;81(4):466-468. doi: 10.1136/annrheumdis-2021-221422. Epub 2021 Oct 16.
6
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?白细胞介素-23在轴性脊柱关节炎和银屑病关节炎中的作用：是否适合生物治疗？
Expert Opin Biol Ther. 2022 Jul;22(7):843-853. doi: 10.1080/14712598.2022.2090834. Epub 2022 Jun 20.
7
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial. Guselkumab 在生物制剂初治活动性中轴型银屑病关节炎患者中的疗效和安全性：STAR 研究方案，一项 4 期、随机、双盲、安慰剂对照试验。
Trials. 2022 Sep 5;23(1):743. doi: 10.1186/s13063-022-06589-y.
8
Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis.轴向型银屑病关节炎的疾病特征、发病机制和治疗争议。
Joint Bone Spine. 2024 Jan;91(1):105625. doi: 10.1016/j.jbspin.2023.105625. Epub 2023 Jul 24.
9
Correspondence on "Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial" by Molto .关于莫尔托所著《严格控制和达标治疗策略在轴性脊柱关节炎中的疗效：开放标签、实用性、整群随机TICOSPA试验结果》的通信
Ann Rheum Dis. 2023 Dec;82(12):e229. doi: 10.1136/annrheumdis-2021-221423. Epub 2021 Nov 1.
10
Similarities and differences between axial spondyloarthritis and axial psoriatic arthritis.轴性脊柱关节炎与轴性银屑病关节炎之间的异同。
Int J Rheum Dis. 2023 Mar;26(3):407-409. doi: 10.1111/1756-185X.14537. Epub 2023 Jan 16.

引用本文的文献

1
Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?轴性脊柱关节炎和银屑病关节炎：主要是重叠性疾病还是截然不同的疾病？
RMD Open. 2023 May;9(2). doi: 10.1136/rmdopen-2023-003063.
2
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.比较轴向银屑病关节炎患者与伴有银屑病的中轴型脊柱关节炎患者：德国 RABBIT-SpA 登记研究的分析。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002837.